WeightLossComparison WeightLossComparison
News and updates

NHS Mounjaro Cohort 2: Am I Eligible Now? (June 2026)

NHS Mounjaro access has expanded to Cohort 2 as of June 2026. Find out whether your BMI and health conditions now qualify you for tirzepatide on the NHS and what to do next.

Published: 23 June 2026 Updated: 23 June 2026 Read time: 4 min read
Information only

This article gives general UK comparison context. Suitability for treatment depends on assessment by a regulated healthcare professional.

Editorial standard

UK-first route, access and evidence framing. U.S. news does not automatically mean UK availability.

Use this page for
  • approval context
  • route comparison
  • NHS and private timing
Read next

Related articles

This week’s comparison update: what changed across costs, tablets and provider notes A short update on current comparison coverage across costs, tablet options, and provider note improvements. Elecoglipron moves to Phase III: what the new oral GLP-1 trial means AstraZeneca has moved elecoglipron into Phase III, adding a new future-tablet headline to the oral GLP-1 conversation. Most people who stop GLP-1 treatment eventually restart New ENDO 2026 data shows many GLP-1 users stop and later restart, which makes switching, maintenance and repeat-review wording more…